Hyperalgesia and increased neuropathic pain-like response in mice lacking galanin receptor 1 receptors

Neuroscience

Volumn 117, Issue 1, 2003, Pages 221-227

  Blakeman, K H ^a   Hao, J X ^a   Xu, X J ^a   Jacoby, A S ^b   Shine, J ^b   Crawley, J N ^c   Iismaa, T ^b   Wiesenfeld Hallin, Z ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Antinociception; Neuropathy; Pain; Spinal cord

Indexed keywords

GALANIN RECEPTOR; GALANIN RECEPTOR 1; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COLD SENSATION; CONTROLLED STUDY; DISEASE DURATION; HEAT SENSATION; HOT PLATE TEST; HYPERALGESIA; HYPERSENSITIVITY; ISCHEMIA; KNOCKOUT GENE; KNOCKOUT MOUSE; MECHANICAL STIMULATION; MOUSE; NERVE INJURY; NEUROPATHY; NOCICEPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN; PRIORITY JOURNAL; SCIATIC NERVE; STIMULUS RESPONSE; STRAIN DIFFERENCE; TAIL FLICK TEST; WILD TYPE;

EID: 0037451797     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00779-0     Document Type: Article

References (32)

1. Bartfai T., Hokfelt T., Langel U. Galanin - a neuroendocrine peptide. Crit Rev Neurobiol. 7:1993;229-274.
2. Branchek T., Smith K.E., Gerald C., Walker M.W. Galanin receptor subtypes. Trends Pharmacol Sci. 21:2000;109-116.
3. Colvin L.A., Mark M.A., Duggan A.W. The effect of a peripheral mononeuropathy on immunoreactive (ir)-galanin release in the spinal cord of the rat. Brain Res. 766:1997;259-261.
4. Colvin L.A., Duggan A.W. Primary afferent-evoked release of immunoreactive galanin in the spinal cord of the neuropathic rat. Br J Anaesth. 81:1998;436-443.
5. Crawley J.N. Galanin-acetylcholine interactions Relevance to memory and Alzheimer's disease. Life Sci. 58:1996;2185-2199.
6. Dray A. Alternatives to mu-opioid analgesics Delta-opioid- and galanin-receptor-selective compounds. Kalso E., McQuay H., Wiesenfeld-Hallin Z. Opioid sensitivity of chronic non-cancer pain. 1999;269-280 IASP Press, Seattle.
7. Eaton M.J., Karmally S., Martinez M.A., Plunkett J.A., Lopez T., Cejas P.J. Lumbar transplant of neurons genetically modified to secrete galanin reverse pain-like behaviors after partial sciatic nerve injury. J Peripher Nerv Syst. 4:1999;245-257.
8. Flatters S.J., Schorge S.H., Fox A.J., Dickenson A.H. Central and peripheral effects of exogenous galanin in na ï ve, sham-operated and neuropathic rats. Abstr Soc Neurosci. 281:2001;4.
9. Hao J.-X., Shi T.-J., Xu I.S., Kaupilla T., Xu X.-J., Hökfelt T., Bartfai T., Wiesenfeld-Hallin Z. Intrathecal galanin alleviates allodynia-like behavior after peripheral nerve injury. Eur J Neurosci. 11:1999;427-432.
10. Hao J.-X., Hygge Blakeman K., Yu W., Hultenby K., Xu X.-J., Wiesenfeld-Hallin Z. Development of a mouse model of neuropathic pain following photochemically-induced ischemia in the sciatic nerve. Exp Neurol. 163:2000;231-238.
11. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
12. Hökfelt T, Bartfai T, Crawley JC (1998) Galanin: Basic research discoveries and therapeutic implications. Ann NY Acad Sci, Vol. 863. New York: New York Academy of Science.
13. Hökfelt T., Wiesenfeld-Hallin Z., Villar M., Melander T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett. 83:1987;217-220.
14. Holmes F.E., Mahoney S., King V.R., Bacon A., Kerr N.C., Pachnis V., Curtis R., Priestley J.V., Wynick D. Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proc Natl Acad Sci USA. 97:2000;11563-11568.
15. Jacoby AS, Holmes FE, Hort YJ, Shine J, Iismaa TP (2002) Phenotypic analysis of Galr1 knockout mice reveals a role for GALR1 galanin receptor in modulating seizure activity but not nerve regeneration. Lett Pept Sci 8:139-146.
16. Ji R.R., Zhang Q., Bedecs K., Arvidsson J., Zhang X., Xu X.-J., Wiesenfeld-Hallin Z., Bartfai T., Hökfelt T. Galanin antisense oligonucleotides reduce galanin levels in dorsal root ganglia and induce autotomy in rats after axotomy. Proc Natl Acad Sci USA. 91:1994;12540-12543.
17. Kerr B.J., Cafferty W.B.J., Gupta Y.K., Bacon A., Wynick D., McMahon S.B., Thompson S.W.N. Galanin knock out mice reveal nociceptive deficits following peripheral nerve injury. Eur J Neurosci. 12:2000;793-802.
18. Kerr B.J., Gupta Y., Pope R., Thompson S.W.N., Wynick D., McMahon S.B. Endogenous galanin potentiates spinal nociceptive processing following inflammation. Pain. 93:2001;267-277.
19. Kinney JW, Wrenn CC, Saavedra MC (2002) Deficits in trace fear conditioning in galanin receptor subtype 1 knockout mice. Soc Neurosci Abstr 82:16.
20. Liu H.X., Brumovsky P., Schmidt R., Brown W., Payza K., Hodzic L., Pou C., Godbout C., Hökefelt T. Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord Selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci USA. 98:2001;9960-9964.
21. Merchenthaler I., Lopez F.J., Negro-Vilar A. Anatomy and physiology of central galanin-containing pathways. Prog Neurobiol. 40:1993;711-769.
22. Pooga M., Hällbrink M., Valkna A., Soomets U., Saar K., Rezaei K., Kahl U., Hao J.-X., Xu X.-J. Cell penetrating PNA antisense oligoneuleotides modify galanergic pain transmission in vivo. Nature Biotech. 16:1998;857-861.
23. Rezaei K., Xu I.S., Wu W.-P., Shi T.-J., Soomets U., Land T., Xu X.-J., Wiesenfeld-Hallin Z., H ökfelt T., Bartfai T., Langel U. Intrathecal administration of PNA targeting galanin receptor reduces galanin-mediated inhibitory effect in the rat spinal cord. NeuroReport. 12:2001;317-320.
24. Tatemoto K., Rökaeus A.̊, Jörnvall H., McDonald T.J., Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164:1983;124-128.
25. Verge V.M., Xu X.J., Langel U.̈, Hökfelt T., Wiesenfeld-Hallin Z., Bartfai T. Evidence for endogenous inhibition of autotomy by galanin in the rat after sciatic nerve section Demonstrated by chronic intrathecal infusion of a high affinity galanin receptor antagonist. Neurosci Lett. 164:1993;193-197.
26. Villar M.J., Cort és R., Theodorsson E., Wiesenfeld-Hallin Z., Schalling M., Fahrenkrug J., Emson P.C., H ökfelt T. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience. 33:1989;587-604.
27. Wiesenfeld-Hallin Z., Bartfai T., H ökfelt T. Galanin in sensory neurons in the spinal cord. Frontiers Neuroendocrinol. 13:1992;319-343.
28. Wiesenfeld-Hallin Z., Villar M.J., H ökfelt T. Intrathecal galanin at low doses increases spinal reflex excitability in rats more to thermal than mechanical stimuli. Exp Brain Res. 71:1988;663-666.
29. Wiesenfeld-Hallin Z., Villar M.J., H ökfelt T. The effect of intrathecal galanin and C-fiber stimulation on the flexor reflex in the rat. Brain Res. 486:1989;205-213.
30. Wiesenfeld-Hallin Z., Xu X.-J., Villar M.J., H ökfelt T. The effect of intrathecal galanin on the flexor reflex in rat Increased depression after sciatic nerve section. Neurosci Lett. 105:1989;149-154.
31. Xu X.-J., H ökfelt T., Bartfai T., Wiesenfeld-Hallin Z. Galanin and spinal nociceptive mechanisms Recent advances and therapeutic implications. Neuropeptides. 34:2001;137-147.
32. Yu L.C., Lundeberg S., An H., Wang F.X., Lundeberg T. Effects of intrathecal galanin on nociceptive responses in rats with mononeuropathy. Life Sci. 64:1999;1145-1153.